Search - tctmd.com

Displaying 141 - 160 of 214

Sort: Relevancy | Date

News Daily News

La Revascularización Coronaria Híbrida es Prometedora para Pacientes de Alto Riesgo

Yael L. Maxwell

April 26, 2013

News Daily News

Hybrid Coronary Revascularization Shows Promise for High-Risk Patients

Yael L. Maxwell

April 26, 2013

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

News Daily News

Underpowered Study Finds Differences Between CABG, PCI in Diabetics

February 19, 2013

News Daily News

Un Estudio No dotado de las Herramientas necesarias Halla Diferencias entre la CABG y la PCI en Diabéticos

February 19, 2013

News Daily News

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Jason Kahn

January 22, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Caitlin E. Cox

December 26, 2012

News Conference News TCT 2012

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

October 24, 2012

News Industry News

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

October 24, 2012

News Industry News

Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2)

October 24, 2012

News Industry News

Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES

October 23, 2012

Presentation TCT 2012

PROTECT: Three-Year Results of a Randomized Mega-Trial of Endeavor vs. Cypher

Presenter: Edoardo Camenzind

October 22, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

News Daily News

La Trombosis del Stent Causa de casi 1 de cada 10 STEMI

October 12, 2012

News Daily News

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

October 12, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

September 19, 2012

Advertisement

La Revascularización Coronaria Híbrida es Prometedora para Pacientes de Alto Riesgo

Hybrid Coronary Revascularization Shows Promise for High-Risk Patients

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

Underpowered Study Finds Differences Between CABG, PCI in Diabetics

Un Estudio No dotado de las Herramientas necesarias Halla Diferencias entre la CABG y la PCI en Diabéticos

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2)

Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES

PROTECT: Three-Year Results of a Randomized Mega-Trial of Endeavor vs. Cypher

COURAGE, FAME: Revascularization More Effective Than OMT

La Trombosis del Stent Causa de casi 1 de cada 10 STEMI

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content